RVP
Reviva Pharms
Stock
Stock
ISIN: US76152G1004
Ticker: RVPH
US76152G1004
RVPH
Price
Price
CHART BY
Frequently asked questions
What is Reviva Pharms's market capitalization?
The market capitalization of Reviva Pharms is $73.13M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Reviva Pharms?
Reviva Pharms's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.106. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Reviva Pharms's stock?
Currently, 6 analysts cover Reviva Pharms's stock, with a consensus target price of $12.14. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for Reviva Pharms?
Reviva Pharms's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$34.50M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Reviva Pharms?
Reviva Pharms has a free cash flow of -$33.32M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Reviva Pharms have, and what sector and industry does it belong to?
Reviva Pharms employs approximately 15 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Reviva Pharms's shares?
The free float of Reviva Pharms is 41.47M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $73.13M
- EPS (TTM)
- -$1.106
- Free Float
- 41.47M
- EBITDA (TTM)
- -$34.50M
- Free Cashflow (TTM)
- -$33.32M
Pricing
- 52W span
- $0.60$4.45
Analyst Ratings
The price target is $12.14 and the stock is covered by 6 analysts.
Buy
6
Hold
0
Sell
0
Information
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
- Employees
- 15
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US76152G1004
- Primary Ticker
- RVPH
Finance data from FactSet